- Home
- WSBCP vs GNLX Comparison
WSBCP vs GNLX Comparison
Compare WSBCP & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBCP
- GNLX
- Stock Information
- Founded
- WSBCP N/A
- GNLX 2001
- Country
- WSBCP United States
- GNLX United States
- Employees
- WSBCP 2195
- GNLX N/A
- Industry
- WSBCP Major Banks
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- WSBCP Finance
- GNLX Health Care
- Exchange
- WSBCP Nasdaq
- GNLX Nasdaq
- Market Cap
- WSBCP N/A
- GNLX 96.6M
- IPO Year
- WSBCP N/A
- GNLX 2023
- Fundamental
- Price
- WSBCP $25.29
- GNLX $2.87
- Analyst Decision
- WSBCP
- GNLX Strong Buy
- Analyst Count
- WSBCP 0
- GNLX 4
- Target Price
- WSBCP N/A
- GNLX $17.75
- AVG Volume (30 Days)
- WSBCP N/A
- GNLX 151.1K
- Earning Date
- WSBCP N/A
- GNLX 08-13-2025
- Dividend Yield
- WSBCP N/A
- GNLX N/A
- EPS Growth
- WSBCP N/A
- GNLX N/A
- EPS
- WSBCP N/A
- GNLX N/A
- Revenue
- WSBCP N/A
- GNLX N/A
- Revenue This Year
- WSBCP N/A
- GNLX N/A
- Revenue Next Year
- WSBCP N/A
- GNLX N/A
- P/E Ratio
- WSBCP N/A
- GNLX N/A
- Revenue Growth
- WSBCP N/A
- GNLX N/A
- 52 Week Low
- WSBCP N/A
- GNLX $1.60
- 52 Week High
- WSBCP N/A
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- WSBCP 61.53
- GNLX 52.48
- Support Level
- WSBCP $25.17
- GNLX $2.75
- Resistance Level
- WSBCP $25.24
- GNLX $3.17
- Average True Range (ATR)
- WSBCP 0.05
- GNLX 0.25
- MACD
- WSBCP 0.01
- GNLX 0.01
- Stochastic Oscillator
- WSBCP 93.30
- GNLX 44.74
About WSBCP WesBanco Inc. Depositary Shares Each Representing a 1/40th Interest in a Share of 6.75% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.